Earnings History Data for Aligos Therapeutics, Inc. (ALGS) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Aligos Therapeutics, Inc.

Aligos Therapeutics, Inc. is a clinical stage biopharmaceutical company. It is focused on the development of antiviral therapies for chronic hepatitis B and coronaviruses as well as liver diseases. Aligos Therapeutics, Inc. is based in SAN FRANCISCO, Calif.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
05-08-2021 AH 4:05 PM ET
(Aug 5)
ALGS Aligos Therapeutics, Inc. 662.14 -0.79 -0.81 0.00 Aligos Therapeutics EPS beats by $0.02
[8/5/2021 4:44 PM]
15.93 -0.30 
(-1.85%)
16.23 0.0 
(0.00%)
12.82 - 37.51 210,543 290,000 471
10-05-2021 AH 4:05 PM ET
(May 10)
ALGS Aligos Therapeutics, Inc. 1,030 -0.74 -0.90 0.00 Aligos Therapeutics EPS beats by $0.16
[5/10/2021 4:57 PM]
26.37 1.34 
(5.35%)
0.0 0.0 
(0.00%)
12.82 - 37.51 66,126 60,000 0